Clinical Trial Update: International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions [NA]

View source ↗

Summary

A completed randomized trial comparing Limus Carbostent with Taxus DES in de novo coronary lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Silent Ischemia
• Stable Angina
• Unstable Angina

Drugs mentioned

• Limus Carbostent (sirolimus-eluting stent)
• Taxus DES (paclitaxel-eluting stent)

Snippet

Sponsor: CID - Carbostent & Implantable Devices | Conditions: Stable Angina, Unstable Angina | NA | Status: COMPLETED